Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Nuvolone

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Biomedicines|May 16, 2023
A Strategy for the Selection of RT-qPCR Reference Genes Based on Publicly Available Transcriptomic DatasetsAlice Nevone, Francesca Lattarulo, Monica Russo, et al.
The Journal of Experimental Medicine|March 2, 2016
Strictly co-isogenic C57BL/6J-Prnp-/- mice: A rigorous resource for prion scienceMario Nuvolone, Mario Hermann, Silvia Sorce, et al.
Analytical Chemistry|January 25, 2019
ATR-FTIR Spectroscopy Supported by Multivariate Analysis for the Characterization of Adipose Tissue Aspirates from Patients Affected by Systemic AmyloidosisDiletta Ami, Paolo Mereghetti, Andrea Foli, et al.
The Journal of Experimental Medicine|May 18, 2016
A neuroprotective role for microglia in prion diseasesCaihong Zhu, Uli S Herrmann, Jeppe Falsig, et al.
Blood|June 30, 2022
Early cardiac response is possible in stage IIIb cardiac AL amyloidosis and is associated with prolonged survivalMarco Basset, Paolo Milani, Andrea Foli, et al.
Blood Advances|April 7, 2020
Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney functionPaolo Milani, Marco Basset, Paola Curci, et al.
Annals of Hematology|September 10, 2008
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomideGiovanni Palladini, Paola Russo, Francesca Lavatelli, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 27, 2025
A novel transthyretin variant p.Val114Glu (Val94Glu) in an Italian patient with mixed phenotype hereditary transthyretin amyloidosisFrancesca Vitali, Mario Nuvolone, Angela Romano, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete responseGiovanni Palladini, Paolo Milani, Marco Basset, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Prognostication of survival and progression to dialysis in AA amyloidosisGiovanni Palladini, Eloisa Riva, Marco Basset, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Biomedicines|May 16, 2023
A Strategy for the Selection of RT-qPCR Reference Genes Based on Publicly Available Transcriptomic DatasetsAlice Nevone, Francesca Lattarulo, Monica Russo, et al.
The Journal of Experimental Medicine|March 2, 2016
Strictly co-isogenic C57BL/6J-Prnp-/- mice: A rigorous resource for prion scienceMario Nuvolone, Mario Hermann, Silvia Sorce, et al.
Analytical Chemistry|January 25, 2019
ATR-FTIR Spectroscopy Supported by Multivariate Analysis for the Characterization of Adipose Tissue Aspirates from Patients Affected by Systemic AmyloidosisDiletta Ami, Paolo Mereghetti, Andrea Foli, et al.
The Journal of Experimental Medicine|May 18, 2016
A neuroprotective role for microglia in prion diseasesCaihong Zhu, Uli S Herrmann, Jeppe Falsig, et al.
Blood|June 30, 2022
Early cardiac response is possible in stage IIIb cardiac AL amyloidosis and is associated with prolonged survivalMarco Basset, Paolo Milani, Andrea Foli, et al.
Blood Advances|April 7, 2020
Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney functionPaolo Milani, Marco Basset, Paola Curci, et al.
Annals of Hematology|September 10, 2008
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomideGiovanni Palladini, Paola Russo, Francesca Lavatelli, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 27, 2025
A novel transthyretin variant p.Val114Glu (Val94Glu) in an Italian patient with mixed phenotype hereditary transthyretin amyloidosisFrancesca Vitali, Mario Nuvolone, Angela Romano, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete responseGiovanni Palladini, Paolo Milani, Marco Basset, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Prognostication of survival and progression to dialysis in AA amyloidosisGiovanni Palladini, Eloisa Riva, Marco Basset, et al.
Pageof 12